L.5. Safety of officers in dismantling illicit synthetic opioid laboratories OP 2 (c) (…) China: We would like to delete the wording from ‘exposure’ to ‘chemicals’. United States: WE would like to remain faithful to the intention of sponsors, which is in line with our policy. This resolution is for all member states but some …
Peru
Committee of the Whole — Monday afternoon session
L.2. Promoting comprehensive, scientific evidence-based and multisectoral national systems of drug use prevention for children Chair: Welcome to the first CoW for the 68th CND session. This committee will have eight meetings, starting this afternoon through to Friday morning. We will suspend our work on Wednesday morning when voting in-person on agenda number 5. A …
Opening of the 68th Session of the CND
Item 1. Election of officers CND Chair. It’s an honour to welcome you to the 68th session of the CND. I thank all my colleagues at the extended bureau and secretariat. With over 2,000 participants, this is one of the largest CNDs. The CND can be followed in Boardroom A and UN Web TV. The …
CND Intersessional – Session 4 – Illicit Trafficking in Substances and Precursors, and Domestic Diversion of Precursor Chemicals
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: Hello, good afternoon, everyone. Welcome back. Let’s begin the afternoon session. Introductory remarks: Mr. Michael Osman, Social Affairs Officer, Border Management Branch, UNODC: I’ll provide a brief overview to leave more time for our interactive discussions …
CND Intersessional – Session 3 – Challenges in Illicit Cultivation and Production of Narcotic Drugs and Psychotropic Substances
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: (Welcome) Secretariat: (organizational matters) Moderator/ intro, Ms. Anja Korenblik, Chief, Geospatial Analysis and Programme Delivery Section, RAB, UNODC: Good morning, everyone. We’ll begin this session on the challenges in the cultivation and production of narcotic drugs and psychoactive substances …
CND Intersessional – Session 2 – Synthetic Opioids and Non-medical Use of Prescription Drugs
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: Welcome back. Ms. Asma Fakhri, UNODC, on behalf of Mr. Justice TETTEY, Chief, Drugs, Laboratory and Scientific Services Branch, UNODC (Moderator): Thank you all for gathering to address the growing challenges posed by synthetic opioids and the non-medical …